DK484479A - Spiro-polycycliske imidazolidindionderivater samt fremgangsmaade til deres fremstilling - Google Patents

Spiro-polycycliske imidazolidindionderivater samt fremgangsmaade til deres fremstilling

Info

Publication number
DK484479A
DK484479A DK484479A DK484479A DK484479A DK 484479 A DK484479 A DK 484479A DK 484479 A DK484479 A DK 484479A DK 484479 A DK484479 A DK 484479A DK 484479 A DK484479 A DK 484479A
Authority
DK
Denmark
Prior art keywords
indion
imidazolide
spiro
polycyclic
procedures
Prior art date
Application number
DK484479A
Other languages
Danish (da)
English (en)
Inventor
R Sarges
J Belletire
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK484479A publication Critical patent/DK484479A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK484479A 1978-11-16 1979-11-15 Spiro-polycycliske imidazolidindionderivater samt fremgangsmaade til deres fremstilling DK484479A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/961,335 US4181728A (en) 1978-11-16 1978-11-16 Spiro-polycyclicimidazolidinedione derivatives

Publications (1)

Publication Number Publication Date
DK484479A true DK484479A (da) 1980-05-17

Family

ID=25504341

Family Applications (1)

Application Number Title Priority Date Filing Date
DK484479A DK484479A (da) 1978-11-16 1979-11-15 Spiro-polycycliske imidazolidindionderivater samt fremgangsmaade til deres fremstilling

Country Status (23)

Country Link
US (1) US4181728A (pt)
JP (2) JPS6052157B2 (pt)
AR (1) AR222052A1 (pt)
AT (1) AT369742B (pt)
AU (1) AU515301B2 (pt)
BE (1) BE880065A (pt)
CA (1) CA1125294A (pt)
CH (1) CH642358A5 (pt)
DE (1) DE2946037A1 (pt)
DK (1) DK484479A (pt)
ES (1) ES486007A1 (pt)
FI (1) FI66385C (pt)
FR (1) FR2441627A1 (pt)
GB (1) GB2038315B (pt)
IE (1) IE49116B1 (pt)
IL (1) IL58730A (pt)
IT (1) IT1127231B (pt)
LU (1) LU81890A1 (pt)
NL (1) NL177689C (pt)
PH (1) PH15672A (pt)
PT (1) PT70452A (pt)
SE (1) SE447731B (pt)
YU (1) YU41678B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU532110B2 (en) * 1979-11-13 1983-09-15 Ici Ltd. Spiro(imidazolidine-4,3:-indoline)-2,2:5-trione derivatives
ATE10940T1 (de) * 1981-05-12 1985-01-15 Imperial Chemical Industries Plc Pyrrolderivate.
US4464385A (en) * 1982-04-15 1984-08-07 Alcon Laboratories, Inc. Treatment of diabetic complications with hydantoins
US4540700A (en) * 1982-04-15 1985-09-10 Alcon Laboratories, Inc. Treatment of diabetic complications with certain spiro-imidazolidine-diones
JPS59500618A (ja) * 1982-04-15 1984-04-12 アルコン・ラボラトリ−ズ・インコ−ポレ−テッド スピロ―フルオロフルオレン化合物、その製造法およびアルド―スレダクターゼ活性を阻害する組成物
US4438272A (en) 1982-04-15 1984-03-20 Alcon Laboratories, Inc. Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones
US4436745A (en) 1982-04-15 1984-03-13 Alcon Laboratories, Inc. Method of inhibiting aldose reductase activity
IL68314A0 (en) * 1982-04-15 1983-07-31 Alcon Lab Inc Method and composition for inhibiting aldose reductase activity and process for preparing spirofluorofluoren and spiro-difluorofluoren compounds
DE3342933A1 (de) * 1983-11-26 1985-06-05 Horst G. 5190 Stolberg Schumann Regalfoerderzeug
US4600717A (en) * 1984-04-11 1986-07-15 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in ophthalmic wound healing
US4717725A (en) * 1984-04-11 1988-01-05 Alcon Laboratories, Inc. Ophthalmic wound healing with aldose reductase inhibitors
US4609663A (en) * 1984-09-11 1986-09-02 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in glaucoma therapy
US4576143A (en) * 1984-10-05 1986-03-18 Clark Iii William T Method of immune modification by means of extracorporeal irradiation of the blood
US4966911A (en) * 1984-11-20 1990-10-30 Washington Research Foundation Immunoregulatory agents
US5340829A (en) * 1984-11-20 1994-08-23 Washington Research Foundation Immunoregulatory agents
JPS6372140U (pt) * 1986-10-29 1988-05-14
JPS63119451U (pt) * 1987-01-30 1988-08-02
WO1992000071A1 (en) * 1989-02-10 1992-01-09 Washington Research Foundation Immunoregulatory agents

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2683718A (en) * 1952-01-11 1954-07-13 Searle & Co Spiro-[xanthene-9, 4'-imidazolidine]-2, 5-dione
DE1032257B (de) * 1954-05-27 1958-06-19 Cutter Lab Verfahren zur Herstellung neuer Hydantoine
GB796069A (en) * 1955-12-23 1958-06-04 Ici Ltd Substituted hydantoins
GB818724A (en) * 1956-10-18 1959-08-19 Ici Ltd Hydantoin derivatives
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4078064A (en) * 1976-08-18 1978-03-07 E. R. Squibb & Sons, Inc. 8H-Pyrazolo[4',3':5,6]pyrido[3,4-e][1,2,4]triazolo[1,5-a]pyrimidines
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4127665A (en) * 1978-01-18 1978-11-28 Pfizer Inc. Thienohydantoin derivatives

Also Published As

Publication number Publication date
LU81890A1 (fr) 1980-06-05
GB2038315B (en) 1982-08-11
IT1127231B (it) 1986-05-21
GB2038315A (en) 1980-07-23
FI66385C (fi) 1984-10-10
FR2441627B1 (pt) 1983-06-03
NL7908352A (nl) 1980-05-20
AR222052A1 (es) 1981-04-15
FR2441627A1 (fr) 1980-06-13
IT7927311A0 (it) 1979-11-15
AU5288079A (en) 1980-05-22
IE49116B1 (en) 1985-08-07
JPS5589268A (en) 1980-07-05
FI66385B (fi) 1984-06-29
CA1125294A (en) 1982-06-08
PH15672A (en) 1983-03-11
NL177689B (nl) 1985-06-03
JPS60120870A (ja) 1985-06-28
ATA729779A (de) 1982-06-15
IE792184L (en) 1980-05-16
SE447731B (sv) 1986-12-08
US4181728A (en) 1980-01-01
SE7909439L (sv) 1980-05-17
ES486007A1 (es) 1980-09-01
DE2946037A1 (de) 1980-05-22
IL58730A0 (en) 1980-02-29
IL58730A (en) 1984-01-31
AU515301B2 (en) 1981-03-26
AT369742B (de) 1983-01-25
CH642358A5 (fr) 1984-04-13
NL177689C (nl) 1985-11-01
YU41678B (en) 1987-12-31
FI793586A (fi) 1980-05-17
JPS6052157B2 (ja) 1985-11-18
PT70452A (en) 1979-12-01
BE880065A (fr) 1980-05-16
JPS6144868B2 (pt) 1986-10-04
YU277379A (en) 1983-01-21

Similar Documents

Publication Publication Date Title
DK20979A (da) 4-amino-5-alkylsulfonyl-0-anisamid-derivater samt fremgangsmaade til fremstilling deraf
DK282880A (da) Aminoalkylbenzen-derivater samt fremgangsmaade til fremstilling deraf
DK222382A (da) Benzezepinderivater fremgangsmaade til deres fremstilling samt deres anvendelse
DK41479A (da) Imidazolderivater og salte deraf samt fremgangsmaade og mellemprodukter til deres fremstilling
DK338379A (da) Pyrazinderivater og fremgangsmaade til deres fremstilling
DK484479A (da) Spiro-polycycliske imidazolidindionderivater samt fremgangsmaade til deres fremstilling
DK528979A (da) Silicageler fremgangsmaade til deres fremstilling samt deres anvendelse
DK291180A (da) Indolizinderivater samt fremgangsmaade til fremstilling deraf
DK150685C (da) Monoazopigmentblandinger samt fremgangsmaade til fremstilling deraf
DK539979A (da) Quinazolinonderivater samt deres fremstilling og anvndelse
DK94880A (da) D-2-hydroxy-4-methylmercaptosmoersyrederivater fremgangsmaade til fremstilling heraf samt anvendelse heraf
DK537677A (da) Propionsyrederivater samt fremgangsmaade til deres fremstilling
DK254780A (da) Alkoxybenzylpyridopyridiner fremgangsmaade til deres fremstilling samt deres anvendelse
DK184679A (da) Substituerede 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepiner fremgangsmaade til deres fremstilling samt deres anvendelse
DK319578A (da) Angiotensinpeptider samt deres fr&mstilling
DK97179A (da) Bicyclooctanderivater samt deres fremstilling og anvendelse
DK458579A (da) Substituerede n-propargylaniliner fremgangsmaade til deres fremstilling samt anvendelse heraf som fungicider
DK494680A (da) Hydroxybutyl-imidazol-derivater fremgangsmaade til deres fremstilling samt deres anvendelse som fungicider
DK92880A (da) 6-beta-substituerede penicillansyrer fremgangsmaade til deres fremstilling samt deres anvendelse
DK191679A (da) Substituerede alkanyl-azolyl-oximcarbamater samt fremgangsmaader til deres fremstilling og deres anvendelse som insecticider acaricider og nematodicider
DK391678A (da) Nitrogen-heterocycliske forbindelser fremgangsmaade til deres fremstilling samt deres anvendelse
DK21579A (da) 5-phenethyl-2-oxazolidon-derivater og fremgangsmaade til deres fremstilling
DK333679A (da) Substituerede pyrazolderivater samt fremgangsmaade til deres fremstilling
DK100081A (da) Quinolinderivater fremgangsmaade til deres fremstilling samt deres anvendelse
DK54179A (da) N-azolylalkyl-anillin samt fremgangsmaader til deres fremstilling

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment